معرفی
Olof Eriksson is a Professor at Uppsala University's Department of Medicinal Chemistry within the Faculty of Pharmacy, where he leads research in translational molecular imaging with a focus on Positron Emission Tomography (PET). His laboratory, affiliated with both Uppsala University and Science for Life Laboratory, applies advanced imaging techniques to study metabolic diseases, particularly diabetes, as well as inflammation, fibrosis, and cancer.
- Faculty of Pharmacy, Uppsala University
- Department of Medicinal Chemistry
- Science for Life Laboratory
- ORCID: 0000-0002-2515-8790
Professor Eriksson's research centers on developing and applying PET imaging techniques to understand and treat metabolic diseases, with particular emphasis on beta cell imaging in diabetes. His work spans molecular probe development, radiopharmaceutical chemistry, and clinical translation of imaging biomarkers. His laboratory has pioneered approaches for imaging beta cell mass, inflammation markers, fibrosis targets, and neuroendocrine pathways using novel radiotracers and Affibody molecules. The research bridges basic science with clinical applications, aiming to improve diagnosis and monitoring of diabetes, inflammatory conditions, and fibrotic diseases.
Analysis of his recent publications reveals a strong focus on translational imaging biomarkers, particularly for diabetes and metabolic disorders. His work increasingly incorporates advanced molecular targeting strategies using Affibody molecules and other affinity reagents for precise imaging of specific cellular targets. The research demonstrates a clear trajectory from probe development through preclinical validation to clinical application, with several studies now reaching first-in-human or clinical patient cohorts.
Professor Eriksson maintains active collaborations across multiple disciplines, working with clinicians, chemists, biologists, and imaging specialists to advance the field of molecular imaging. His research program includes both fundamental probe development and application of imaging techniques to address specific clinical questions in diabetes, inflammation, and fibrosis.
